Document Page: First | Prev | Next | All | Image | This Release | Search
File: 120396_sep96_decls75_0005.txt
Subject: BIOLOGICAL WARFARE DEFENSE MEDICAL GUIDELINES
Unit: OTSG
Parent Organization: HSC
Box ID: BX003203
Folder Title: BIOLOGICAL WARFARE DEFENSE MEDICAL GUIDELINES
Document Number: 1
Folder SEQ #: 196
UNCLASSIFIED
PRIORITY TOD
DEPOSITED IN ALVEOLI OR ALVEOLAR DUCTS WHERE THEY ARE
PHAGOCYTI7-ED BY ALVEOLAR MACROPHAGES AND CARRIED TO MEDIASTINAL
PAGE 03 RHIPAAA\'\",\ S E C R E T
LYMPH NODES. A HEMORRHAGIC MEDIASTINITIS RESULTS, FOLLOWED BY
BACTEREMIA AND INTRAVASCULAR MULTIPLICATION OF ORGANISMS.
MENINGITIS OFTEN OCCURS AS A PART OF THE OVERWHELMING
SEPTICEMIA. INHALATION A14THRAX IS VERY DIFFICULT TO DIAGNOSE
EARLY. 'THE DISEASE IS BIPHASIC, AND INITIAL SYMPTOMS MIMIC A
SI=VERF VIRAL RESPIRATORY ILLNESS LII.-ZE INFLUENZA. THIS LASTS FOR
2 TO 3 DAYS AND IS FOLLOWEII BY A SECOND MORE ACUTE PHASE
CHARACTERIZED BY SEVERE HYPOXIM@ AND OYSPNEA- CHEST X-RAY FILMS
CONSISTENTLY SHOW WIDENING OF THE MEI3IASTINUM. PATIENTS SOON
BECOME HYPOTENSIVE, AND ABOUT ONE-HALF DEVELOP MERAINGEAL SIGNS.
BACILLUS ANTHRACIS CELLS ARE LARGE. GRAM-POSITIVE BACILLI AND
INDIVIDUAL CELLS HAVE SOUARE OR CONCAVE ENDS. OVOID,
SUBTERMINAL ENDOSPORES THAT DO NOT CAUSE ANY SIGNIFICANT
SWELLING OF THE CELLS MAY BE OBST:R%)FD. THE SPORES APPEAR AS
UNSTAINED AREAS WITHIN THE BACTERIAL CELLS IN GRAM'S STAINED
PREPARATION. THE ORGANISM GROWS WELL ON ORDINARY BLOOD AGAR
WITHIN 13 TO 24 HOURS AT 35 DEGREES CENTIGRADE. THE COLONIES
ARE TYPICALLY FLAT AND IRREGULAR. 4 MM TO 5 MM IN DIAMETER AND
IS NOT HEMOLYTIC ON SHEEP BLOOD AGAR.
FEW GOOI3 DATA EXIST ON THE TREATMENT OF INHALATION ANTHRAX BUT
PAGE 04 RHIPAAA\\\\
RECENT ANIMAL STUDIES HAVE PROMPTED THE ARMED FORCES
EPIDEMIOLOGY BOARD TO RECOMMEND TREATMENT OF SUSPICIOUS CLINICAL
SYMPTOMS WITH A LOADING DOSE OF CIPROFLOXACIN (IOOC) MGM)
FOLLOWED BY 7@@O MGM TWICE A DAY, INTRAVENOUS IDOXYCYCLINE (2C)C)
MGM LOADING DOSE FDLLOWED BY I(:)O MGM TWO TIMES DAILY), OR OTHER
APPROPRIATE ANTIBIOTICS SUCH AS HIGH DOSE PENICILLIN. IF THE
PATIENT HAS HA13 PRE-E'@'POSUPE VACCINATION, AN ADDITIONAL BOOSTER
IS RECOMMENDED DURING THERAPY. IF NO PRE-EXPOSURE VACCINATION
HAS OCCURED, INITIATION OF THE VACCINATION SERIES WHILE ON
ANTIBIOTICS IS RECOMMENDED.
THE HUMAN ANTHRAX '@'ACCINE IS FDA APPROVED AND CONSISTS OF
ALUM-PRECIPITATr-'-l PROTECTIVE ANTIGEN FROM FERMENTOR CULTURES OF
TOXIGENIC, NON-ENCAPSULATED STRAINS OF BACILLUS ANTHRACI-@. IT
CONTAINS FORMALIN AND BEN-@ETHONIUM CHLORIDE.@ THE VACCINE SERIES
IS A TWO SHOT SERIFS TWO WEEK@D APART WITH A BOOSTER RECOMMENDED.
SIX PER CENT WILL EXPERIENCE MILD LOCAL DISCOMFORT AT THE
INOCULATION SITE AWE, LESS THAN ONE PER CENT WILL HAVF MORE
SEVERE LOCAL REACTION. ALL CAN EXPECT =SOME BURNING AT THE
Ir4jECTIDII SITE FOR UP TD TWD MINUTES AFTER 11@IJECTIDII. 1%10
ANAPHYL-"CTIC REACTIONS HAVE BEEN EXPERIENCED IN
VW VW VW
FRIORITY - - - - - -
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 8 f:/Week-36/BX003203/BIOLOGICAL WARFARE DEFENSE MEDICAL GUIDELINES/biological warfare defense medical guidelines:11259610131215
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = BIOLOGICAL WARFARE DEFENSE MEDICAL GUIDELINES
Folder Seq # = 196
Subject = BIOLOGICAL WARFARE DEFENSE MEDICAL GUIDELINES
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 25-NOV-1996